Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP
Report ID | 8417 |
Drug Identification Number | 02347830 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | ROPIVACAINE |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION EPIDURAL |
Packaging size | 10x10mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-05-09 |
Estimated end date | |
Actual end date | 2018-10-01 |
Shortage status | Resolved |
Updated date | 2018-10-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.